Medical Devices US

US Angioplasty Balloons Market Analysis, 2024–2034

Updated Reviewed by Chandani Patel

US Angioplasty Balloons Market Analysis Industry Trends and Forecast to 2034: Segmented by (By Product Type, By Material, By Application, By End User, By Region) - Growth, Market Size, Future Prospects & Competitive Analysis, 2024-2034

Overview

Market Dashboard

US · 2024–2034 · placeholder estimates

Values shown here are placeholder estimates, not researched figures. Researched 2024 historical, 2025 base-year and 2026–2034 forecast values are prepared with the full report.

Estimate 2024 $1.74 Bn Placeholder estimate
Estimate 2025 $1.77 Bn 40.4% of the global market
Projected 2034 $2.07 Bn 17.4% Adds $307.8 Mn over 9 forecast years
CAGR 2025–2034 1.8% Faster than 1% of 186 Medical Devices markets here
Key players 6 +1
  • US is 40.4% of the global market.
  • In North America, the largest is US (this report) at $1.77 Bn.
  • Fastest growing: Canada at 3.8% a year.
  • US ranks 1st of 2 by size in North America.

Market size projection

US

Source: Acuitas Health Analytics. Full methods, sources and usage terms come with report purchase.

Value added each year

$307.8 Mn total, 2026–2034

Year-by-year market size, 2024–2034
Angioplasty Balloons Market market size by year, US
YearMarket sizeChange that yearSince 2025
2024 (estimate) $1.74 Bn — —
2025 (base) $1.77 Bn +$31.2 Mn —
2026 (forecast) $1.80 Bn +$31.8 Mn +1.8%
2027 (forecast) $1.83 Bn +$32.4 Mn +3.6%
2028 (forecast) $1.86 Bn +$33.0 Mn +5.5%
2029 (forecast) $1.90 Bn +$33.6 Mn +7.4%
2030 (forecast) $1.93 Bn +$34.2 Mn +9.3%
2031 (forecast) $1.97 Bn +$34.8 Mn +11.3%
2032 (forecast) $2.00 Bn +$35.4 Mn +13.3%
2033 (forecast) $2.04 Bn +$36.0 Mn +15.3%
2034 (forecast) $2.07 Bn +$36.7 Mn +17.4%

Placeholder estimates. Each year is projected from our earlier market estimate and its CAGR. Researched values come with the full report.

Report snapshot

US Angioplasty Balloons Market Analysis at a glance
Market size, 2025$1.77 Bn placeholder estimate
Forecast, 2034$2.07 Bn placeholder estimate
Growth (CAGR), 2025–20341.8% placeholder estimate
Years2024 historical · 2025 base year · 2026–2034 forecast
SegmentsProduct type, material, application and end user (see all)
Key playersAbbott Laboratories, Boston Scientific Corporation, Medtronic, B. Braun Melsungen AG, Biotronik SE & Co. KG and 1 more (see all)
Regulator in the USFDASource: US Food and Drug Administration. Checked 14 Nov 2026.
Active clinical trials52 in the USSource: ClinicalTrials.gov, Studies recruiting, active or not yet recruiting, in the US. Retrieved 9 Nov 2026.
FormatsPDF, PPTX, XLSX

Sizes and growth here are placeholder estimates, not researched figures. Researched figures come with the full report.

The US Angioplasty Balloons Market Executive Summary

Angioplasty balloons are medical devices that are utilized in angioplasty, which is a process of opening up blocked or narrowed arteries. The balloon is positioned on the catheter and placed through the blood vessel. Once in place, the balloon is inflated, which forces plaque against the arterial wall and opens up the artery to enhance blood flow.

The global angioplasty balloon market is expanding due to increase in cardiovascular diseases, innovation, and increased population of geriatrics. Critical product categories include plain and drug-coated balloons, and the major markets are North America, Europe, and APAC, rapidly growing. The problems are cost and potential legal issues. There is an increased emphasis on innovation and strategic partnerships among top companies. The market outlook is promising, growth is expected owing to improvements in technology and uses in the developing world.

Bar chart: US Angioplasty Balloons market size, 2024–2034, placeholder estimates. $1.74 Bn in 2024, $1.77 Bn in 2025 and $2.07 Bn in 2034, 1.8% CAGR.
US Angioplasty Balloons market size, 2024–2034. Placeholder estimates; researched figures come with the full report. Source: Acuitas Health Analytics.

US Angioplasty Balloons Market Dynamics

Market Growth Drivers

Growth of the angioplasty balloons market is attributed to the increasing rates of cardiovascular diseases, including coronary artery disease, which requires angioplasty. The trend of moving toward less invasive procedures such as balloon angioplasty has also been driving the entry due to their advantages such as low recovery time. Innovations like drug-eluting and scoring balloons are improving procedure efficiency and minimizing restenosis threat. Furthermore, there is an increasing prevalence of the geriatric population that has a higher risk of developing cardiovascular diseases, and the revenue policies of North America region are encouraging in this regard.

Opportunity

The angioplasty balloons market has future opportunities in the extension of technology related to drug-eluting and bioresorbable balloons in combination with enhanced imaging systems. Another important trend is the shift towards less invasive treatments and the growth of the healthcare sector in developing countries. Thus, the improved public consciousness and better development of key associations will bring more advancement in innovation and the global marketplace.

Market Restraints

Some of the challenges faced in the angioplasty balloons market are steep procedure costs that make it difficult to afford the product and possible complications like bleeding and heart attack that can discourage the use of the balloons. It can also reduce adoption due to the absence of reimbursement policies, as well as the confined and regulated avenues that digital interventions need to pass through before being approved. However, there are several issues that may slow down the growth of market, including a lack of qualified staff and a tendency to turn to non-conventional approaches.

Competitive Landscape for Angioplasty Balloons Market in the US

Key Players

Recent Developments

March 2024, Boston Scientific Corporation today announced it has received USFDA approval for the AGENT™ Drug-Coated Balloon, which is indicated to treat coronary in-stent restenosis (ISR) in patients with coronary artery disease. ISR is the obstruction or narrowing of a stented vessel by plaque or scar tissue.

April 2024, Abbott announced that the USFDA has approved the Esprit™ BTK Everolimus Eluting Resorbable Scaffold System (Esprit BTK System), a breakthrough innovation for people with chronic limb-threatening ischemia (CLTI) below-the-knee (BTK). The Esprit BTK System is designed to keep arteries open and deliver a drug (Everolimus) to support vessel healing prior to completely dissolving.

January 2024, Summa Therapeutics, LLC announced that the company’s Finesse Injectable balloon catheter platform was used in first-in-human injectable angioplasty procedures for patients with below-the-knee (BTK) peripheral artery disease (PAD).

Mergers and Acquisitions

November 2025, OrbusNeich Medical Group Holdings Limited, a major global medical device manufacturer specializing in interventional devices for percutaneous coronary intervention (PCI) and percutaneous transluminal angioplasty (PTA) procedures, today announced the acquisition of 100% interest in Eucatech AG, a German company principally engaged in the development, manufacture, and sale of minimally invasive cardiovascular and endovascular projects, for EUR2,400,000.

October 2025, Cordis acquires drug-eluting balloon maker MedAlliance for up to $1.135B.

November 2022, Johnson & Johnson announced a definitive agreement for the acquisition of Abiomed, a leader in heart support and recovery technologies, with an upfront payment of USD 380 per share, which equates to USD 16.6 billion.

Healthcare Policies and Regulatory Landscape for Angioplasty Balloons Market in the US

Angioplasty Balloons in the US: rules, payment and research

The FDA clears or approves medical devices by risk class, through 510(k) clearance, De Novo classification or premarket approval (PMA).⁠[1] Medicare covers people aged 65 and over and some younger people with disabilities, and Medicaid covers many people on low incomes; both are run with the Centers for Medicare & Medicaid Services (CMS).⁠[2] ClinicalTrials.gov lists 52 studies on Angioplasty Balloons that are recruiting, active or about to start in the US.⁠[3]

[1] US Food and Drug Administration. Checked 14 Nov 2026.

[2] Centers for Medicare & Medicaid Services. Checked 14 Nov 2026.

[3] ClinicalTrials.gov, Studies recruiting, active or not yet recruiting, in the US. Retrieved 9 Nov 2026.

Policy changes and Reimbursement scenario

Market factors that drive market growth include approval of new policies that enhance the utilization of healthcare services, and regulatory approval of new devices such as drug-coated balloons. The focus on using non-invasive strategies corresponds to the positive aspects linked to angioplasty operations. Insured clients especially in North American region increases adoption of solution while insurance reimbursement policies that may be invariable helps increase the market. Other government initiatives for restricting the prices of healthcare services and enhancing access also contribute to the market.

Beyond the market numbers

Research, trials and patients

What doctors and scientists are doing in Angioplasty Balloons right now, from free public sources.

Sources: PubMed (US National Library of Medicine), ClinicalTrials.gov, World Bank. Fetched 9 Nov 2026. Papers and trials are found by search words, so the counts are a guide. Titles only; read each paper at its source.

Public data, with sources

Angioplasty Balloons in context

The US compared

  • Health spending per person: 13,473 US$ per person (2023). World: 1,317 US$ per person (2023).[1]
  • Doctors: 3.68 per 1,000 people (2022). World: 1.86 per 1,000 people (2022).[2]
  • People aged 65 and over: 18.4% of people (2025). World: 10.4% of people (2025).[3]

[1] World Bank Open Data, Health spending per person (US$ per person). Retrieved 22 Nov 2026.

[2] World Bank Open Data, Doctors (per 1,000 people). Retrieved 21 Nov 2026.

[3] World Bank Open Data, People aged 65 and over (% of people). Retrieved 21 Nov 2026.

Free data on this topic

Inside the US

Quick answers

Frequently asked questions

How big is the Angioplasty Balloons market in the US?
Placeholder estimate: about $1.77 Bn in 2025, rising to about $2.07 Bn by 2034. These are early estimates, not researched figures; the researched values come with the full report.
How fast is the Angioplasty Balloons market in the US growing?
Placeholder estimate: about 1.8% a year (CAGR, 2025–2034). The researched growth rate comes with the full report.
What segments does the Angioplasty Balloons market report cover?
The report splits the market by product type (Normal Balloons, Drug-Coated Balloons, Cutting Balloons, Scoring Balloons), material (Non-Compliant Balloons, Semi-Compliant Balloons), application (Coronary Angioplasty, Peripheral Angioplasty) and end user (Hospitals, Ambulatory Surgical Canters (ASCs), Catheterization Laboratories, Specialty Clinics).
Who are the key players in the Angioplasty Balloons market?
Key players include Abbott Laboratories, Boston Scientific Corporation, Medtronic, B. Braun Melsungen AG, Biotronik SE & Co. KG and Terumo Corporation.
What is driving the Angioplasty Balloons market?
Growth of the angioplasty balloons market is attributed to the increasing rates of cardiovascular diseases, including coronary artery disease, which requires angioplasty.
Who regulates Angioplasty Balloons in the US?
The FDA clears or approves medical devices by risk class, through 510(k) clearance, De Novo classification or premarket approval (PMA). Source: US Food and Drug Administration. Checked 14 Nov 2026.
How is healthcare paid for in the US?
Medicare covers people aged 65 and over and some younger people with disabilities, and Medicaid covers many people on low incomes; both are run with the Centers for Medicare & Medicaid Services (CMS). Source: Centers for Medicare & Medicaid Services. Checked 14 Nov 2026.
How many clinical trials on Angioplasty Balloons are running in the US?
52 studies are recruiting, active or about to start in the US, according to ClinicalTrials.gov. Source: ClinicalTrials.gov, Studies recruiting, active or not yet recruiting, in the US. Retrieved 9 Nov 2026.
How much research is published on Angioplasty Balloons?
PubMed lists 4,003 papers on Angioplasty Balloons added since January 2021, worldwide. Source: PubMed, Papers added since 1 January 2021 matching this market. Retrieved 9 Nov 2026.
Back to Catalogue

Related Medical Devices reports in US

See all

Related on cardiovascular

See the topic